Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Rational Control of Fluid Balance in the Intensive Care Unit
NCT02345681Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- May 2015
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of furosemide in Fluid overload, sponsored by CHU de Nantes. Started May 2015; status: completed.
02
Drugs
furosemide
03
Conditions
Fluid overload
Beyond the preview
Go deeper on NCT02345681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02345681.